申请人:National Cancer Center
公开号:EP3639821A1
公开(公告)日:2020-04-22
An object of the present invention is to provide a carcinogenesis inhibitor having no side effect and having an excellent effect by oral administration.
A carcinogenesis inhibitor of the present invention containing a hydantoin derivative or a pharmaceutically acceptable salt thereof as an active ingredient shows an inhibiting action for polyp formation and for cell proliferation, and has no side effect and highly safe whereby it is very highly useful as a pharmaceutical agent and a food such as supplement which prevent the occurrence and progress of cancer, inhibits the recurrence and metastasis of cancer and further achieves the therapeutic effect.
本发明的目的是提供一种口服无副作用且效果极佳的致癌物抑制剂。
本发明的一种致癌抑制剂含有一种海因衍生物或其药学上可接受的盐作为有效成分,对息肉的形成和细胞增殖有抑制作用,且无副作用,安全性高,因此作为药物制剂和食品(如保健品)非常有用,可以防止癌症的发生和发展,抑制癌症的复发和转移,并进一步达到治疗效果。